In a significant breakthrough for the development of supercritical carbon dioxide (sCO 2) power cycles, the 10-MWe Supercritical Transformational Electric Power (STEP) Demo pilot plant in San Antonio, ...
Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...
Kymera's KT-621 shows promising STAT6 degradation in Phase 1 trials, with favorable safety and planned further studies in 2025. KT-621 demonstrated superior Th2 biomarker reductions compared to ...
Kymera Therapeutics, Inc. announced that it will release results from its Phase 1 clinical trial of KT-621, an investigational oral degrader medicine targeting the STAT6 transcription factor linked to ...
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results